市場調査レポート

世界のデジタル病理診断システム市場

Digital Pathology Systems

発行 Global Industry Analysts, Inc. 商品コード 269628
出版日 ページ情報 英文 175 Pages
納期: 即日から翌営業日
価格
本日の銀行送金レート: 1USD=106.71円で換算しております。

ご注意:Single user licenseはDRM(デジタル著作権管理システム)付PDFとなります。
PDFの閲覧には Adobe Digital Editions (無償)のインストールが必要となります。
認証されたPC上のみでの閲覧と、1回のプリントアウトが可能となっております。

Back to Top
世界のデジタル病理診断システム市場 Digital Pathology Systems
出版日: 2015年01月01日 ページ情報: 英文 175 Pages
概要

当レポートでは、世界のデジタル病理診断システム市場について調査分析し、製品セグメント別、地域(米国、カナダ、日本、欧州、アジア太平洋地域、ラテンアメリカなど)別に、市場実績と予測、主要企業プロファイルなどを含めて、体系的な情報を提供しています。

第1章 イントロダクション・調査手法・製品の定義

第2章 エグゼクティブサマリー

  • 産業の概要
    • はじめに
    • 不況の影響
    • 市場の見通し
    • 主な問題点
    • 将来
  • 市場促進要因・動向・問題点
    • 組織分析における自動化の必要性
    • ワークフロー効率
    • 病理医の不足と過剰なワークフロード
    • 早期診断の必要性
    • 臨床研究
    • 技術の進歩
    • デジタル病理診断の可能性
    • デジタル病理診断システム
    • 癌・慢性疾患での急速な導入
    • ホステッド技術へと移行
    • サービスとしてのデジタル病理診断、他
  • 競合
  • 製品の概要
  • 製品の発売/イノベーション
  • 最近の産業活動
  • 世界の主要企業
    • 3DHISTECH Ltd.(ハンガリー)
    • AccelPath, Inc.(米国)
    • Apollo PACS, Inc.(米国)
    • Carl Zeiss AG(ドイツ)
    • Corista LLC(米国)
    • Definiens AG(ドイツ)
    • DigiPath Inc.(米国)
    • Flagship Biosciences, LLC(米国)
    • Koninklijke Philips Electronics N.V.(オランダ)
    • Leica Microsystems GmbH(ドイツ)
    • MikroScan Technologies, Inc.(米国)
    • Olympus America, Inc.(米国)
    • Omnyx, LLC(米国)
    • Pixcelldata Ltd.(アイルランド)
    • Ventana Medical Systems, Inc.(米国)
    • VMscope GmbH(ドイツ)
  • 世界市場の見通し

第3章 市場

  • 米国
  • カナダ
  • 日本
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • その他

第4章 競合情勢

  • 競合企業プロファイル:50社(事業部/子会社を含めると54社)
    • 米国
    • カナダ
    • 日本
    • 欧州
    • アジア太平洋地域(日本を除く)

このページに掲載されている内容は最新版と異なる場合があります。詳細はお問い合わせください。

目次
Product Code: MCP-6740

This report analyzes the worldwide markets for Digital Pathology Systems in US$ Thousands. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Latin America, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 50 companies including many key and niche players such as -

3DHISTECH Ltd.
AccelPath, Inc.
Apollo PACS, Inc.
Carl Zeiss AG
Corista LLC

Table of Contents

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

  • Study Reliability and Reporting Limitations
  • Disclaimers
  • Data Interpretation & Reporting Level
    • Quantitative Techniques & Analytics
  • Product Definitions and Scope of Study

II. EXECUTIVE SUMMARY

1. INDUSTRY OVERVIEW

  • A Prelude
  • Impact of Economic Recession in Retrospect & the Road Ahead
  • Market Outlook
  • Developed Markets to Maintain their Dominance
  • Digital Pathology Systems See Fast Paced Growth in Emerging Nations
  • Analytics: A Fast Growing Segment
  • Key Issues Hampering the Wider Adoption of Digital Pathology Systems
  • The Future in Retrospect

2. MARKET DRIVERS, TRENDS & ISSUES

  • The Need for Automation in Tissue Analysis
  • Workflow Efficiencies: A Key Market Driver for Digital Pathology Systems
  • Scarcity of Pathologists & Excess Workload on Pathology Labs Drives Demand for Digital Systems
  • Need for Early Diagnosis Puts Focus on Digital Pathology
  • Clinical Research Continues to be Core Vertical for Digital Pathology
  • Technological Advances Ease Issues in Digital Pathology Adoption
  • Possibilities Ahead in Digital Pathology
  • Digital Pathology Systems Continue to Widen their Scope
  • Digital Pathology Systems See Fast Paced Adoption in Cancer and Other Chronic Diseases
  • Move towards Hosted Technology: The New Fad
  • Digital Pathology as a Service Eludes Cost-based Issues
  • Telepathology Expected to Pave Way for Pathology Outsourcing to Developing Nations
  • Rising Emphasis on Lab Automation Extends Opportunity for Digital Pathology
  • Rising Penetration of Personalized Medicine Bodes Well for Digital Pathology
  • Increased Focus on Companion Diagnostics to Benefit the Market
  • Improving Healthcare & Research Expenditures Turbo Charge Digital Pathology
    • Table 1: Per-Capita Healthcare Expenditure in Select Regions (2013) (includes corresponding Graph/Chart)
    • Table 2: Top 20 Countries with the Highest Healthcare Spending as a Percentage of GDP (2012) (includes corresponding Graph/Chart)
  • Burgeoning Global Population: A Strong Business Case for Market Growth
    • Table 3: Top 25 Countries Worldwide in Terms of Population: 2007, 2010 & 2013 (includes corresponding Graph/Chart)
  • Aging Population: A Key Opportunity Indicator
    • Table 4: Global Population Statistics for the 65+ Age Group (2013) (includes corresponding Graph/Chart)
    • Table 5: Elderly Population (60+ Years) as a Percentage of the Total Population (2012 & 2050) (includes corresponding Graph/Chart)
    • Table 6: Global Aging Population by Age Group: 1975-2050 (includes corresponding Graph/Chart)
    • Table 7: Aging Population by Age Group in More Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 8: Aging Population by Age Group in Less Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 9: Aging Population by Age Group in Least Developed Countries (1975-2050) (includes corresponding Graph/Chart)
    • Table 10: Life Expectancy at Age 60 and 80 Years - (2010-2015), (2020-2025) & (2045-2050) (includes corresponding Graph/Chart)
  • Key Issues Hampering the Wider Adoption of Digital Pathology Systems
  • High Costs
  • Workflow Integration with Other Related Functions
  • Other Issues

3. COMPETITION

  • Leica Dominates the Market
    • Table 11: Leading Players in the Global Digital Pathology Systems Market (2013): Percentage Breakdown of Dollar Sales for Leica, Olympus, Roche/Ventana and Others (includes corresponding Graph/Chart)
  • Consolidation Rife in the Digital Pathology Space

4. PRODUCT OVERVIEW

  • An Introduction to Pathology
  • Digital Pathology: Computer-Enabled Pathology Process
  • Digital Pathology System: Components
  • Slide Scanners
  • Analytics
  • Storage
  • Communication
  • Applications
  • Remote Reviewing
  • Digital-Assisted Mathematical Analysis
  • Data Storage
  • Telepathology
    • Static Telepathology
    • Dynamic Telepathology
    • Hybrid Telepathology
  • Bio-banking
  • Multinational Integration
  • Tissue Microarray Analysis
  • A Review of Information Archival and Retrieval in Digital Pathology
  • Storage and Interoperability
  • Location and Internal Communication
  • Systems and Data Reliability
  • Image Life-Cycle Management
  • IT infrastructure and Management Costs
  • Factors Affecting Information Archival
  • Digital Pathology Management Systems
  • Benefits of Digital Pathology Systems
  • Easier Analysis and Archival & Retrieval of Digital Images
  • Access to Digital Slide Images Anytime Anywhere

5. PRODUCT INTRODUCTIONS/INNOVATIONS

  • Philips Obtains CE Mark Approval for Diagnostic Use of its Philips Digital Pathology Solution
  • Mikroscan Technologies Unveils Mikroscan L6 and the Mikroscan MC2 Telepathology Systems
  • Royal Philips Receives FDA 510(k) Clearance for Her2/neu IHC Digital Manual Read Product
  • Ventana Medical Systems Launches iScan HT Slide Scanner
  • Ventana Obtains FDA 510(k) Clearance for VENTANA Companion Algorithm Ki-67 (30-9) Image Analysis Solution

6. RECENT INDUSTRY ACTIVITY

  • Visiopharm Begins Operations in Benelux
  • Pixcelldata Selects Edge Solutions as its US Partner
  • CellNetix Pathology and Laboratories Merges with Highline Pathology Associates
  • Definiens Teams Up with Clarient Diagnostic Services
  • Pixcelldata Signs Partnership Deal with eX-Path
  • Pixcelldata Inks Partnership Agreement with Basys Data
  • IDEXX Laboratories Inks Collaboration Agreement with Royal Philips
  • Ventana Medical Systems and EMC Join Hands
  • XIFIN Acquires PathCentral
  • Kanteron Systems Signs Joint Selling & Marketing Agreement with DigiPath
  • DigiPath Inks New Agreement with Personalized Diagnostic
  • Dako to Launch Clinical Image Analysis for Digital Pathology
  • Ventana Medical Systems Inks Global Agreement with Barco
  • MEDITE Teams Up with UNIC Technologies
  • Leica Biosystems Takes Over Aperio Technologies
  • Carl Zeiss MicroImaging and Olympus America Sign Licensing Agreement
  • Aperio Technologies and Dell Enter into Strategic Collaboration
  • AccelPath Acquires DigiPath Solutions
  • Leica Microsystems and Indica Labs Sign Agreement
  • Omnyx™ Receives CE Mark in Europe
  • Erasmus MC Selects Philips to Adopt Digital Pathology System

7. FOCUS ON SELECT GLOBAL PLAYERS

  • 3DHISTECH Ltd. (Hungary)
  • AccelPath, Inc. (US)
  • Apollo PACS, Inc. (US)
  • Carl Zeiss AG (Germany)
  • Corista LLC (US)
  • Definiens AG (Germany)
  • DigiPath Inc. (US)
  • Flagship Biosciences, LLC (US)
  • Koninklijke Philips Electronics N.V. (Netherlands)
  • Leica Microsystems GmbH (Germany)
  • MikroScan Technologies, Inc. (US)
  • Olympus America, Inc. (US)
  • Omnyx, LLC (US)
  • Pixcelldata Ltd. (Ireland)
  • Ventana Medical Systems, Inc. (US)
  • VMscope GmbH (Germany)

8. GLOBAL MARKET PERSPECTIVE

    • Table 12: World Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 13: World Historic Review for Digital Pathology Systems by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 14: World 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Revenues for US, Canada, Japan, Europe, Asia-Pacific (excluding Japan), Latin America and Rest of World Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

III. MARKET

1. THE UNITED STATES

  • A. Market Analysis
    • Current & Future Analysis
    • Market Overview
    • Increasing Pressure on Pathological Labs - An Opportunity in Disguise
    • Regulatory Scenario in the US
      • Health Insurance Portability and Accountability Act (HIPAA)
      • Food and Drug Administration (FDA)
      • Clinical Laboratory Improvement Amendments (CLIA)
    • Approval Status
    • Product Launches
    • Strategic Corporate Developments
    • Key Players
  • B. Market Analytics
    • Table 15: US Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 16: US Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

2. CANADA

  • A. Market Analysis
    • Current & Future Analysis
    • Need for Digital Pathology in Canada
  • B. Market Analytics
    • Table 17: Canadian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 18: Canadian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

3. JAPAN

  • A. Market Analysis
    • Current & Future Analysis
    • Digital Pathology in Japan - An Overview
  • B. Market Analytics
    • Table 19: Japanese Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 20: Japanese Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4. EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 21: European Recent Past, Current and Future Analysis for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 22: European Historic Review for Digital Pathology Systems by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets Independently Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)
    • Table 23: European 15-Year Perspective for Digital Pathology Systems by Geographic Region - Percentage Breakdown of Revenues for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2006, 2014 and 2020 (includes corresponding Graph/Chart)

4a. FRANCE

  • Market Analysis
    • Table 24: French Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 25: French Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4b. GERMANY

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 26: German Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 27: German Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4c. ITALY

  • Market Analysis
    • Table 28: Italian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 29: Italian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4d. THE UNITED KINGDOM

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 30: UK Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 31: UK Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4e. SPAIN

  • Market Analysis
    • Table 32: Spanish Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 33: Spanish Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4f. RUSSIA

  • Market Analysis
    • Table 34: Russian Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 35: Russian Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

4g. REST OF EUROPE

  • A. Market Analysis
    • Current & Future Analysis
    • Strategic Corporate Developments
    • Select Players
  • B. Market Analytics
    • Table 36: Rest of Europe Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 37: Rest of Europe Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

5. ASIA-PACIFIC

  • A. Market Analysis
    • Current & Future Analysis
    • Asia-Pacific: Gradually Embracing Telepathology
    • Market Exhibits Faster Growth
    • South Korea: Limited Adoption despite Adequate Networking Infrastructure
    • China: Static Telepathology Remains Popular
    • Inadequate Infrastructure Impedes Adoption of Digital Pathology in India
    • Strategic Corporate Development
  • B. Market Analytics
    • Table 38: Asia-Pacific Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 39: Asia-Pacific Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

6. LATIN AMERICA

  • Market Analysis
    • Table 40: Latin American Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 41: Latin American Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

7. REST OF WORLD

  • A. Market Analysis
    • Current & Future Analysis
    • Africa: Digital Pathology finds Few Takers
  • B. Market Analytics
    • Table 42: Rest of World Recent Past, Current and Future Analysis for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2013 through 2020 (includes corresponding Graph/Chart)
    • Table 43: Rest of World Historic Review for Digital Pathology Systems Market Analyzed with Annual Revenues in US$ Thousand for Years 2006 through 2012 (includes corresponding Graph/Chart)

IV. COMPETITIVE LANDSCAPE

Back to Top